Assura (LON:AGR) Shares Cross Above 200 Day Moving Average – Here’s Why

Assura Plc (LON:AGRGet Free Report)’s share price crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 47.90 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares traded.

Analyst Ratings Changes

Several research firms have issued reports on AGR. Shore Capital restated a “hold” rating on shares of Assura in a research note on Wednesday, October 1st. Peel Hunt reiterated a “buy” rating and set a GBX 60 target price on shares of Assura in a research note on Tuesday, September 30th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Assura has an average rating of “Moderate Buy” and an average price target of GBX 60.

View Our Latest Stock Analysis on Assura

Assura Price Performance

The stock has a market capitalization of £1.54 billion, a price-to-earnings ratio of 895.85, a P/E/G ratio of 3.60 and a beta of 0.37. The company’s 50-day simple moving average is GBX 47.48 and its 200-day simple moving average is GBX 47.90. The company has a debt-to-equity ratio of 85.05, a current ratio of 0.89 and a quick ratio of 2.84.

Assura Company Profile

(Get Free Report)

Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.

We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).

Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.

Further Reading

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.